MedTrace Logo

Non-invasive Determination of Anemia in Children With Renal Failure

NCT02369237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2015-02-23

No results posted yet for this study

Summary

Anemia and inflammation are very common in patients with renal diseases. The most common procedure to detect anemia is to determine blood hemoglobin concentrations. The Haemospect® is a portable device for non-invasive hemoglobin determination that works with a sensor that is applicable in infants and adults alike.

The objective of this trial is to collect spectra with the non-invasive Haemospect® device in children of different age groups with renal failure and different hemoglobin concentrations. In parallel, corresponding hemoglobin values shall be obtained invasively to form the basis for the development of an algorithm for the device.

To determine inflammation, the frequencies of vasomotion and oxygenation of the tissue are measured non-invasively with the Haemospect®. Various blood parameters for iron and inflammation will also be determined, such as ferritin, hepcidin, transferrin, serum iron, white blood cell count and CRP.

Conditions

  • Renal Failure

Sponsors & Collaborators

  • Hildegrad Grunow Foundation

    collaborator UNKNOWN

  • MBR Optical Systems

    collaborator UNKNOWN

  • Center for Studies of Sensory Impairment, Aging and Metabolism

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02369237 on ClinicalTrials.gov